Future looks brighter for Australian biotech investors

02/4/2006 | Australian (tiered subscription model), The

Australian investment professionals believe the country's biotech industry may be turning the corner from one plagued with false starts and disappointments to one producing milestones with more products entering late-stage trials. But the sector remains a risky one with a long wait for a payback and still requires careful research on the part of the investor.

View Full Article in:

Australian (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA